Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.verified

TNXP

Price:

$0.4031

Market Cap:

$75.34M

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises...[Read more]

Industry

Biotechnology

IPO Date

2012-05-10

Stock Exchange

NASDAQ

Ticker

TNXP

The Enterprise Value as of December 2024 (TTM) for Tonix Pharmaceuticals Holding Corp. (TNXP) is 52.98M

According to Tonix Pharmaceuticals Holding Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 52.98M. This represents a change of 1.87% compared to the average of 2.69M of the last 4 quarters.

Tonix Pharmaceuticals Holding Corp. (TNXP) Historical Enterprise Value (quarterly & annually)

How has TNXP Enterprise Value performed in the past?

The mean historical Enterprise Value of Tonix Pharmaceuticals Holding Corp. over the last ten years is -31049149.02. The current 52.98M Enterprise Value has changed -17161.97% with respect to the historical average. Over the past ten years (40 quarters), TNXP's Enterprise Value was at its highest in in the September 2022 quarter at 592.02M. The Enterprise Value was at its lowest in in the June 2022 quarter at -109094048.00.

Quarterly (TTM)
Annual

Average

-31049149.02

Median

-22104500.00

Minimum

-105237791.80

Maximum

-8266033.80

Tonix Pharmaceuticals Holding Corp. (TNXP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tonix Pharmaceuticals Holding Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 382.00%

Maximum Annual Enterprise Value = -8266033.80

Minimum Annual Increase = -92.15%

Minimum Annual Enterprise Value = -105237791.80

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-8266033.80-92.15%
2022-105237791.80122.21%
2021-47359264.64297.73%
2020-11907400.009.33%
2019-10891000.00-56.50%
2018-25034000.00-1.81%
2017-25496000.0034.61%
2016-18941000.00-1.22%
2015-19175000.00-49.78%
2014-38184000.00382.00%

Tonix Pharmaceuticals Holding Corp. (TNXP) Average Enterprise Value

How has TNXP Enterprise Value performed in the past?

The current Enterprise Value of Tonix Pharmaceuticals Holding Corp. (TNXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-53621030.08

5-year avg

-36732298.05

10-year avg

-31049149.02

Tonix Pharmaceuticals Holding Corp. (TNXP) Enterprise Value vs. Peers

How is TNXP’s Enterprise Value compared to its peers?

Tonix Pharmaceuticals Holding Corp.’s Enterprise Value is greater than Sonnet BioTherapeutics Holdings, Inc. (4.31M), greater than Onconova Therapeutics, Inc. (32.62M), greater than Palisade Bio, Inc. (-2842535.00), greater than iBio, Inc. (14.79M), greater than Jaguar Health, Inc. (32.52M), greater than Acasti Pharma Inc. (14.78M), greater than Diffusion Pharmaceuticals Inc. (10.50M), less than Vaxart, Inc. (132.93M), greater than VBI Vaccines Inc. (39.99M), less than Bright Minds Biosciences Inc. (379.53M), greater than Virax Biolabs Group Limited (4.97M), less than Novavax, Inc. (1.04B), greater than Inovio Pharmaceuticals, Inc. (-9177522000.00), greater than Enveric Biosciences, Inc. (40.99K), greater than CohBar, Inc. (-4359535.00),

Build a custom stock screener for Tonix Pharmaceuticals Holding Corp. (TNXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonix Pharmaceuticals Holding Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tonix Pharmaceuticals Holding Corp. (TNXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tonix Pharmaceuticals Holding Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tonix Pharmaceuticals Holding Corp.'s Enterprise Value?

What is the highest Enterprise Value for Tonix Pharmaceuticals Holding Corp. (TNXP)?

What is the 3-year average Enterprise Value for Tonix Pharmaceuticals Holding Corp. (TNXP)?

What is the 5-year average Enterprise Value for Tonix Pharmaceuticals Holding Corp. (TNXP)?

How does the current Enterprise Value for Tonix Pharmaceuticals Holding Corp. (TNXP) compare to its historical average?